BCRX

7.2201.37%
AG

Alan G. Levin

Independent Director

Mr. Alan G. Levin, CPA, serves as an Independent Director at BioCryst Pharmaceuticals, Inc. since February 27, 2020. He has been the Non-Executive Chairman of Aceto Corp. since July 2018 and its Director from 2013 to 2019. He served as Vice Chairman of Aceto Corp. since April 18, 2018 until July 1, 2018. Mr. Levin first joined the ACETO Board in December 2013 and held that role until 2019 and served as Lead Independent Director since July 2016 until July 1, 2018. He served as the Chief Financial Officer and Executive Vice President at Endo Pharmaceuticals Solutions Inc., Endo Health Solutions Inc. and Endo International plc from June 1, 2009 until September 2013. Prior to joining Endo, Mr. Levin worked with Texas Pacific Group. Mr. Levin served as Senior Vice President and Chief Financial Officer at Pfizer Inc. from March 3, 2005 to August 22, 2007, where he worked for many years in a variety of executive positions of increasing responsibility. He joined Pfizer, Inc. (OLD) in 1987 and served as its Senior Operations Auditor for the Controller's Division. He worked at Pfizer for over many years in a variety of executive capacities, including Treasurer and Senior Vice President of Finance & Strategic Management for the its research and development organization. He played an integral role in over a dozen acquisition, divestiture and other business development transactions. He has extensive experience in strategic planning, capital markets, financial reporting, tax planning and business development. Mr. Levin oversaw the design and implementation of a broad array of financial strategies, as well as the restructuring of various parts of the company's operations through the implementation of shared services, focused and disciplined outsourcing of non-core operations, the implementation of enterprise-wide systems, the streamlining and rationalization of diverse processes and procedures and a tighter integration of support functions and core operations. In 1988, he joined the Treasurer's Division and served as its Controller of Pfizer International Bank in San Juan, Puerto Rico. He served as Director of Finance for Asia of Pfizer International Bank since 1991 and also served as Senior Director of Finance for Asia since 1993. Mr. Levin served as Treasurer of Pfizer International Bank since 1995. He served as Vice President of Pfizer International Bank since 1997. Since 2003, he served as Senior Vice President of PGRD Finance & Strategic Management. Since September 2000, he served as Vice President of Finance with oversight responsibility for Pfizer's Corporate Tax, Treasurers and Controllers Divisions. He served as the Chief Financial Officer of moksha8 Pharmaceuticals, Inc. He served as Treasurer since 1995 and served as Vice President of PGRD Finance & Strategic Management since 1997 with additional responsibilities for the Corporate Tax Division. He served as a Director of Restorgenex Corporation since January 8, 2016. He has been a Director of HealthTronics Inc. since July 2, 2010. He was an Independent Director of Diffusion Pharmaceuticals Inc. since January 2016 until August 2023 and as a Director of Diffusion LLC since June 2015. He serves as a Member of Advisory Board at Auven Therapeutics Management L.L.L.P. He is a Director of Critical Path Institute. Mr. Levin is an Editorial Advisor for the Journal of Accountancy and a Member of the Finance Council of the American Management Association. Prior to joining Pfizer, he worked at Arthur Andersen & Co., where he qualified as a certified public accountant. Mr. Levin received his Certified Public Accountant from AICPA and earned his Master's Degree in Accounting from New York University's Stern School of Business and a Bachelor's Degree from Princeton University.

Positions